Literature DB >> 7569571

[Epidemiological data. Neonatal and prenatal screening].

J P Farriaux1, J L Dhondt.   

Abstract

Unlike what is generally thought, cystic fibrosis is not the most frequent hereditary disease. Its frequency is approximately 1/3 200 and varies with the geographic area. The frequency of heterozygous subjects is about 1/28. No country has established a generalized neonatal screening programme, for technical reasons and because there has been no demonstration of a beneficial effect from early care. It would nevertheless be useful to develop experimental programmes defining which protocols might best be established. Antenatal screening can be based on detecting heterozygous subjects, a technically feasible operation, although answers to a large number of questions would be required.

Entities:  

Mesh:

Year:  1995        PMID: 7569571

Source DB:  PubMed          Journal:  Rev Pneumol Clin        ISSN: 0761-8417


  2 in total

1.  Development of the Cystic Fibrosis Questionnaire (CFQ) for assessing quality of life in pediatric and adult patients.

Authors:  Bernadette Henry; Pierre Aussage; Cécile Grosskopf; Jean-Marie Goehrs
Journal:  Qual Life Res       Date:  2003-02       Impact factor: 4.147

2.  Blood concentrations of pancreatitis associated protein in neonates: relevance to neonatal screening for cystic fibrosis.

Authors:  J Sarles; S Barthellemy; C Férec; J Iovanna; M Roussey; J P Farriaux; A Toutain; J Berthelot; N Maurin; J P Codet; P Berthézène; J C Dagorn
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.